Skip to Content
High contrast: Off On
High Contrast Mode Has Been Turned Off

Health tech startups vie for a piece of drug supply chain

  • Oct 13, 2021
  • Pharmacy Benefit Management
A TECH TWIST ON DRUG BENEFITS: Can a group of health tech startups disrupt the world of pharmacy benefit managers and seize part of a market forecast to be worth as much as $700 billion by the middle of the decade?

Companies such as Capital Rx, WithMe Health and Navitus see an opening, and are using high tech dashboards and data mining in a bid to supplant industry giants, who now manage drug benefits for health insurers, employers and other payers.

These challengers hope to capitalize on the growing scrutiny of PBMs' role in health spending — especially the practice of “spread pricing,” in which companies charge payers more than they reimburse pharmacies for certain drugs, and pocket the difference.

Read more by clicking the link to the full article below.

View the Article Online